NO20060095L - Celler anvendt som baerere for bakterier - Google Patents

Celler anvendt som baerere for bakterier

Info

Publication number
NO20060095L
NO20060095L NO20060095A NO20060095A NO20060095L NO 20060095 L NO20060095 L NO 20060095L NO 20060095 A NO20060095 A NO 20060095A NO 20060095 A NO20060095 A NO 20060095A NO 20060095 L NO20060095 L NO 20060095L
Authority
NO
Norway
Prior art keywords
bacteria
carriers
cells used
pharmaceutical composition
active substance
Prior art date
Application number
NO20060095A
Other languages
English (en)
Norwegian (no)
Inventor
Werner Goebel
Ivaylo Gentschev
Joachim Fensterle
Ulf Rapp
Jochen Strizker
Andreas Schmidt
Tamara Potapenko
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of NO20060095L publication Critical patent/NO20060095L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/17—Monocytes; Macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/45—Bacterial antigens
    • A61K40/4562—Salmonella; Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20060095A 2003-06-06 2006-01-06 Celler anvendt som baerere for bakterier NO20060095L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10326187A DE10326187A1 (de) 2003-06-06 2003-06-06 Zellen als Träger für Bakterien
PCT/DE2004/001178 WO2004108155A1 (de) 2003-06-06 2004-06-07 Zellen als träger für bakterien

Publications (1)

Publication Number Publication Date
NO20060095L true NO20060095L (no) 2006-03-03

Family

ID=33494937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060095A NO20060095L (no) 2003-06-06 2006-01-06 Celler anvendt som baerere for bakterier

Country Status (15)

Country Link
US (1) US20060240038A1 (sr)
EP (1) EP1631310A1 (sr)
JP (1) JP2006526396A (sr)
KR (1) KR20060090164A (sr)
CN (1) CN1802175A (sr)
AU (1) AU2004244701A1 (sr)
BR (1) BRPI0411210A (sr)
CA (1) CA2526789A1 (sr)
DE (2) DE10326187A1 (sr)
IL (1) IL172129A0 (sr)
NO (1) NO20060095L (sr)
RS (1) RS20050907A (sr)
RU (1) RU2006100021A (sr)
WO (1) WO2004108155A1 (sr)
ZA (1) ZA200509476B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3004924A1 (en) * 2015-11-10 2017-05-18 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity
CN109563481B (zh) * 2016-07-13 2024-01-05 俄亥俄州创新基金会 用于优化宿主抗原呈递和宿主抗肿瘤和抗病原体免疫的平台和方法
CN114540228B (zh) * 2022-02-21 2024-01-23 上海交通大学医学院附属仁济医院 一种经光热剂修饰的细菌、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024961A (en) * 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
US6783765B2 (en) * 2001-03-23 2004-08-31 Council Of Scientific And Industrial Research Process for the preparation of a vaccine for the treatment of tuberculosis and other intracellular infections diseases and the vaccine produced by the process
EP1373475A2 (en) * 2001-04-02 2004-01-02 Alimentary Health Limited Immunotherapy based on dendritic cells

Also Published As

Publication number Publication date
CA2526789A1 (en) 2004-12-16
CN1802175A (zh) 2006-07-12
KR20060090164A (ko) 2006-08-10
BRPI0411210A (pt) 2006-07-18
WO2004108155A1 (de) 2004-12-16
DE10326187A1 (de) 2005-01-05
ZA200509476B (en) 2006-08-30
IL172129A0 (en) 2006-04-10
DE112004001497D2 (de) 2006-04-27
US20060240038A1 (en) 2006-10-26
AU2004244701A1 (en) 2004-12-16
EP1631310A1 (de) 2006-03-08
JP2006526396A (ja) 2006-11-24
RS20050907A (sr) 2007-09-21
RU2006100021A (ru) 2006-05-27

Similar Documents

Publication Publication Date Title
ES2674328T3 (es) Nuevas bacterias de ácido láctico y composiciones que las contienen
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
WO2005044179A3 (en) Formulations containing astragalus extracts and uses thereof
EP2305276A3 (en) Processed lipoaspirate cells for use in therapy
BR0210791A (pt) Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma
DE69839699D1 (de) Vaginales lactobacillus-medikament
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
EP2465923A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
MX9708854A (es) Terapia de genes para regulacion de celulas efectoras.
EA200600424A1 (ru) Применение полипептидов семейства купредоксинов при лечении рака
Walter et al. Moderate effect of enamel matrix derivative (Emdogain® Gel) on Porphyromonas gingivalis growth in vitro
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
BRPI0409023A (pt) meio da cultura, método para preparar o citado meio, coleta e clonagem de células tronco, água micro-agregada, composição e método para prepará-la
NO20060095L (no) Celler anvendt som baerere for bakterier
JP2020073475A (ja) 生存菌類寄生微生物ピシウム・オリガンドラムを含む、皮膚および粘膜の皮膚糸状菌症および酵母感染症の処置用製剤、微生物ピシウム・オリガンドラムの細胞生存率を決定する方法ならびに該製剤の適用方法
Padaru et al. CRISPR/Cas‑mediated targeted gene editing of Streptococcus mutans: A promising approach for precision dentistry for the prevention and management of caries
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
Obst et al. Diversity of patients microflora on orthopaedic and dental implants
Bienvenue et al. In Vitro Evaluation of the Efficacy of an Aqueous Extract of Allium Sativum as an Antibacterial Agent on Three Major Periodontal Pathogen
EP3397240A1 (en) Carbohydrate fraction isolated from a clarified lysate obtained from a biomass of bacteria belonging to the genusvitreoscilla sp
BR0318058A (pt) Processo para a preparação fermentativa de l-aminoácidos usando cepas da famìlia enterobacteriaceae que contêm uma sequência orf yjgf atenuada
CN104622871A (zh) 一种恶唑酮类化合物作为变异链球菌生物膜抑制剂的应用
CN115770195A (zh) 一种稳定的祛痘组合物及其制备方法
CZ33363U1 (cs) Potravinářský výrobek nebo výživový doplněk obsahující kmen mikroorganismu Lactobacillus plantarum

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application